RE:RE:todays trades
Agreed. I got in after they put their Covid-19 work on temporary hold. I believe that the company has other good projects in progress.
"Vaxil’s strategy remains focused on delivering long-term value based on the unique benefits of SP's including their broad and robust immune response, both cellular and humoral, their reduced sensitivity to genetic mutation and manufacturing efficiency, especially in oncology. To that end, the Company continues to strengthen the value proposition of SPs across these therapeutic areas, by demonstrating the ability to generate a robust and consistent immune response."
Also, they say that they have the financial means to keep going at these present projects. Let's see what will happen down the road. I expect good things but like all good things it takes time.